Loading...
Medical Marijuana, Inc.
MJNA•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$-0.00(-33.33%)
Medical Marijuana, Inc. (MJNA) Financial Performance & Statements
Review Medical Marijuana, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-11.33%
↓ 11.33%
Operating Income Growth
99.97%
↑ 99.97%
Net Income Growth
87.38%
↑ 87.38%
Operating Cash Flow Growth
138.45%
↑ 138.45%
Operating Margin
-0.01%
↓ 0.008%
Gross Margin
78.22%
↑ 78.22%
Net Profit Margin
-4.30%
↓ 4.30%
ROE
-1.28%
↓ 1.28%
ROIC
-0.00%
↓ 0.002%
Medical Marijuana, Inc. (MJNA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Medical Marijuana, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.43M | $3.83M | $3.56M | $4.08M |
| Cost of Revenue | $917280.00 | $812564.00 | $692533.00 | $823916.00 |
| Gross Profit | $2.52M | $3.02M | $2.87M | $3.26M |
| Gross Profit Ratio | $0.73 | $0.79 | $0.81 | $0.80 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.59M | $2.98M | $2.60M | $3.49M |
| Operating Expenses | $2.59M | $2.98M | $2.60M | $3.49M |
| Total Costs & Expenses | -$3.51M | -$3.79M | $3.29M | $4.32M |
| Interest Income | $74471.00 | $73111.00 | $69744.00 | $67992.00 |
| Interest Expense | $0.00 | $264065.00 | $23971.00 | $33707.00 |
| Depreciation & Amortization | $80232.00 | $63478.00 | $63249.00 | $66965.00 |
| EBITDA | -$379625.00 | $426997.00 | -$407038.00 | $313726.00 |
| EBITDA Ratio | -$0.11 | $0.11 | -$0.11 | $0.08 |
| Operating Income | -$74948.00 | $38647.00 | $272638.00 | -$237470.00 |
| Operating Income Ratio | -$0.02 | $0.01 | $0.08 | -$0.06 |
| Other Income/Expenses (Net) | -$384907.00 | $60811.00 | -$766895.00 | $450529.00 |
| Income Before Tax | -$459855.00 | $99458.00 | -$494257.00 | $213059.00 |
| Income Before Tax Ratio | -$0.13 | $0.03 | -$0.14 | $0.05 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $5.00 |
| Net Income | -$459855.00 | $99458.00 | -$494257.00 | $213059.00 |
| Net Income Ratio | -$0.13 | $0.03 | -$0.14 | $0.05 |
| EPS | -$0.00 | $0.00 | -$0.00 | $0.00 |
| Diluted EPS | -$0.00 | $0.00 | -$0.00 | $0.00 |
| Weighted Avg Shares Outstanding | $6.77B | $5.84B | $5.23B | $5.05B |
| Weighted Avg Shares Outstanding (Diluted) | $6.77B | $5.84B | $5.23B | $5.05B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan